Hale Advisors

Don’t miss this essential new reference on omnichannel, modular & promotional review practices in pharma. Claims, business rules, 2253 submissions & more. ⬇ Feedback in comments. From the peer-reviewed journal of RAPS. Citation: Dunn Z. Navigating the shift to omnichannel marketing. Regulatory Focus. Published online 25 January 2024. https://lnkd.in/eXDJB8Ek Author: Zoë Dunn in Regulatory Affairs Professionals Society (RAPS) #pharmamarketing #omnichannel #modularcontent #marketingoperations #promotionalreview #mlr #marketinggovernance #digitalgovernance #changemanagement  

When Marissa Mayer was heading search products at Google, she spoke of how constraints can focus problems, citing haiku as one example of creativity triumphing over the rules. Inherent to this concept of constraints spurring innovation is the notion that they must coexist “with a healthy disregard for the impossible.” So, constraints + vision = innovation. This truth has been borne out in studies and widely published over the years. So why then, in highly regulated industries like life sciences, is the chief constraint of compliance restrictions still seen as an obstacle to innovation? From a marketing perspective, it’s perhaps because the compliance restrictions aren’t well defined. Enter Marketing Guidelines. Marketing Guidelines define and refine requirements for compliant execution. Rather than stifle marketers and their agency partners, Guidelines provide parameters within which they can solve the communications problem. Ultimately, it’s both providing and embracing the guidance that leads to breakthrough solutions. #PharmaMarketing #MarketingGovernance #MarketingGuidelines #PromotionalReview

In the age of misinformation, Confidence in Content℠ is crucial for patients, HCPs, and the brands that serve them. How confident are you that pharma content generated from pre-approved modules, AI, or automated processes is correct, effective, and compliant? Especially if it’s published without final Promotional Review? A solid Marketing Governance Framework can help, including a structure, processes, Guidelines, communications, and training that govern and support content creation, review, and activation. Evaluate your proficiency with a Modular Content Readiness Assessment. Message us to learn more.

ANSWER: What is inefficiency in the content creation and Promotional Review process? If your Promotional Review “feels like a sorority intake process,” as one client described it, you can take steps to diagnose and address the root cause. Your first step? Compare your performance versus industry averages on key Marketing Operations metrics such as: • Days to enter review • Number of review cycles • Days in review • Days to approval Assuming consistent use of your content and review management platform, the data should be accessible and reliable. You might then determine the out-of-pocket costs and revenue loss resulting from any extra days, rework, and delay to market. Armed with data and benchmarks, you’ll be in good shape to examine the effectiveness and utilization of your Marketing Governance throughout the process. #PharmaMarketing #MarketingGovernance #PromotionalReview #MarketingOperations

Is CFL a pain point in your promotional review process? You could have it solved by Labor Day. Our Fundamentals of CFL eModule: • Coaches teams to perform FDA’s three-factor analysis • Trains on evidentiary support and CFL communications best practices • Creates advanced CFL understanding quickly Available now for light customization and rapid deployment. Ask us for a demo. #PharmaMarketing #PharmaTraining #CFL #MarketingGovernance

Being able to promote data and information that is consistent with (but not contained within) an Rx brand's FDA-required label (CFL) can be a game-changer. The first step? Learn how FDA uses its three-factor analysis to determine whether a product communication is CFL-compliant. #PharmaMarketing #MarketingGovernance #MarketingGuidelines

Wishing all our US clients and friends a happy July 4 celebration!

Want to promote data and information about approved/cleared uses that aren’t contained in—but are consistent with—an Rx brand’s FDA-required labeling (CFL)? The FDA’s CFL Guidance helps companies comply with the requirements for conveying that data and information in a truthful and non-misleading way. Understanding how to apply the Guidance is key to success. Have you mastered the three factors? #PharmaMarketing #MarketingGovernance #MarketingGuidelines

"Smart risk" is defined at a company level and enables commercial marketers to strategically and safely apply all tools at their disposal to be innovative while also protecting patients and the brand. Are your company's standards clear? #PharmaMarketing #MarketingGovernance #MarketingGuidelines

A dynamic marketing environment demands dynamic Marketing Governance. But new or amended Marketing Guidelines and processes are only effective when teams put them to use. Depending on the situation, best practices to drive uptake can include simple but effective: • Communications programs • Influencer activation • Case studies • Playbooks • Training support • Resistance management • Incentives and recognition How do you manage changes to your Marketing Governance and Guidelines? #PharmaMarketing #MarketingGovernance #ChangeManagement #MarketingGuidelines #MarketingOperations